Morningstar

Aimwell Partners Inc AIMN

Stock OTCM

News

Your Patients Know Your Name, But Does AI? AimwellBio Expands Its Healthcare Platform and Invites the Public to Nominate Professionals Worth Knowing

ACCESS Newswire Oct 19, 2026, 12:30:00 PM
After One Clinic Said Yes, the Phone Started Ringing. AIMN Opens Applications for Practices to Be Featured Next.

ACCESS Newswire Oct 14, 2026, 12:30:00 PM
The People Verifying Your Healthcare Should Not Be the People Selling It. AimwellBio Launches Provider Verification Registry in Connecticut.

ACCESS Newswire Oct 6, 2026, 12:30:00 PM
Patients Are Asking AI About Their Health; AimwellBio Wants Verified Physicians to Be Part of the Answer

ACCESS Newswire Oct 1, 2026, 12:55:00 PM
The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It

ACCESS Newswire Sep 15, 2026, 12:30:00 PM
AimwellBio Puts Its Global Intelligence Map in Public View, No Login Required, as Dr. Chris A. Jones Builds Out the Advisory Bench Behind it

ACCESS Newswire Sep 2, 2026, 12:30:00 PM
The IP Was Only Half the Acquisition: Aimwell Bio Closes the Trustr IP Purchase and Begins Bringing Aboard the People Who Built It

ACCESS Newswire Aug 27, 2026, 12:30:00 PM
AimwellBio Secures Patented Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of Advisors

ACCESS Newswire Aug 17, 2026, 12:45:00 PM
AimwellBio Publishes Investor Briefing on Acquired Trustr Intellectual Property Portfolio Valued at $10m Reinforcing Commitment to Transparency

ACCESS Newswire Aug 13, 2026, 1:00:00 PM
Aimwell Partners Announces Agreement in Principle to Acquire Intellectual Property Valued at Approximately $10 Million

ACCESS Newswire Aug 6, 2026, 12:30:00 PM
The World's Most Valuable Healthcare Database May Already Exist, The Problem Is Nobody Knows Who to Trust Inside It

ACCESS Newswire Jul 27, 2026, 1:30:00 PM

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.